掃描關(guān)注 
EDTA K2/EDTA K3
紫頭管中的抗凝劑為 EDTA 鹽。國際血液委員會推薦使用抗凝效率較高 , 穩(wěn)定性更強(qiáng) , ph 值與血液相對接近的乙二胺四乙酸 · 二鉀(EDTA.K2)。 獨(dú)一無二的內(nèi)壁仿生活性膜處理 , 有效地維持了血小板的活性穩(wěn)定。微噴霧技術(shù)的運(yùn)用降低 了因血小板黏附與聚集而發(fā)生血小板損失和凝血的風(fēng)險(xiǎn) ,嚴(yán)格的微粒污染控制工藝杜絕了微粒污染對檢驗(yàn)結(jié)果的影響。 Purple cap use EDTA salt as anticoagulant. ICSH recommends using EDTA.K2, which is with higher anticoagulation efficiency, stronger stability and relatively closer ph value with blood. The unique imitated life film treatment on its inner wall can effectively maintain the active stability of platelet. The application of micro atomizing technology has lowered the hazard of platelet loss and blood coagulation caused by platelet adherence and gathering. And the rigorous particle pollution control technology has completely eradicated the impact on test result caused by particle pollution.
EDTA K2/EDTA K3
